Tehran University of Medical Sciences

Science Communicator Platform

Share By
Association Between Cardiometabolic Risk Factors and Covid-19 Susceptibility, Severity and Mortality: A Review Publisher



Sharifi Y1, 2 ; Payab M3 ; Mohammadivajari E4 ; Aghili SMM1 ; Sharifi F5 ; Mehrdad N6, 7 ; Kashani E8 ; Shadman Z5 ; Larijani B1 ; Ebrahimpur M5
Authors

Source: Journal of Diabetes and Metabolic Disorders Published:2021


Abstract

The novel coronavirus, which began spreading from China Wuhan and gradually spreaded to most countries, led to the announcement by the World Health Organization on March 11, 2020, as a new pandemic. The most important point presented by the World Health Organization about this disease is to better understand the risk factors that exacerbate the course of the disease and worsen its prognosis. Due to the high majority of cardio metabolic risk factors like obesity, hypertension, diabetes, and dyslipidemia among the population over 60 years old and higher, these cardio metabolic risk factors along with the age of these people could worsen the prognosis of the coronavirus disease of 2019 (COVID-19) and its mortality. In this study, we aimed to review the articles from the beginning of the pandemic on the impression of cardio metabolic risk factors on COVID-19 and the effectiveness of COVID-19 on how to manage these diseases. All the factors studied in this article, including hypertension, diabetes mellitus, dyslipidemia, and obesity exacerbate the course of Covid-19 disease by different mechanisms, and the inflammatory process caused by coronavirus can also create a vicious cycle in controlling these diseases for patients. © 2021, Springer Nature Switzerland AG.
3. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
Experts (# of related papers)
Other Related Docs
16. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
20. Management of Environmental Health to Prevent an Outbreak of Covid-19: A Review, Environmental and Health Management of Novel Coronavirus Disease (COVID-19) (2021)